Subscribe to RSS
DOI: 10.1055/a-1674-5724
Breastfeeding Associated with Lower Prevalence of Metabolic Syndrome in Women with Gestational Diabetes in the Very Early Postpartum Period
Funding This study was funded by the Centers of Disease Control and Prevention (grant no: HHSD2002013M53968B).![](https://www.thieme-connect.de/media/ajp/202401/lookinside/thumbnails/10-1055-a-1674-5724_210278-1.jpg)
Abstract
Objective The aim of this study is to examine the association of breastfeeding with metabolic syndrome (MetS) in women with recent gestational diabetes mellitus (GDM) in the very early postpartum (PP) period.
Study Design We performed a secondary analysis of the Balance After Baby Intervention (BABI) study which enrolled women with recent GDM. Data collected during an early (~8 weeks) PP visit were used in this analysis. At this visit, weight, height, waist circumference (WC), blood pressure (BP), fasting plasma glucose (FPG), and lipids were obtained. MetS was classified per National Cholesterol Education Program Adult Treatment Program III (NCEP-ATP III) criteria. We defined breastfeeding as currently breastfeeding or not currently breastfeeding for the main analysis.
Results Of 181 women enrolled in BABI, 178 were included in this analysis (3 excluded for missing lipids). Thirty-four percent were Hispanic. Of non-Hispanics, 31.5% were White, 18.5% Asian, and 12.9% Black/African American. The prevalence of MetS was 42.9% in women not breastfeeding versus 17.1% in women breastfeeding (p < 0.001; adjusted odds ratio [aOR] = 0.16 [95% confidence interval (CI): 0.06–0.41]). Breastfeeding women had significantly lower odds of FPG ≥100 mg/dL (aOR = 0.36 [95% CI: 0.14–0.95], p = 0.039), HDL < 50 mg/dL (aOR = 0.19 [95% CI: 0.08–0.46], p < 0.001), and triglycerides (TG) ≥ 150 mg/dL (aOR = 0.26 [95% CI: 0.10–0.66], p = 0.005). When evaluated as continuous variables, WC, FPG, and TG were significantly lower and HDL significantly higher in women breastfeeding in the very early PP period (vs. not breastfeeding).
Conclusion In a diverse population of women with recent GDM, there was lower prevalence of MetS in women breastfeeding compared with those not breastfeeding in the very early PP period. This study extends the findings of an association of breastfeeding with MetS previously reported at time points more remote from pregnancy to the very early PP period and to an ethnically and racially diverse population.
Key Points
-
MetS prevalence in women with recent GDM was lower in breastfeeding than not breastfeeding women.
-
FPG, HDL, WC, and TG were improved in the breastfeeding group.
-
This study extends prior findings to the very early PP period and to a diverse population.
Keywords
women's health - metabolic syndrome - breastfeeding - gestational diabetes mellitus - lactation - postpartum* These authors contributed equally to the article.
Publication History
Received: 13 April 2021
Accepted: 03 October 2021
Accepted Manuscript online:
20 October 2021
Article published online:
14 December 2021
© 2021. Thieme. All rights reserved.
Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
-
References
- 1 Sattar N, Greer IA. Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening?. BMJ 2002; 325 (7356): 157-160
- 2 Rich-Edwards JW, McElrath TF, Karumanchi SA, Seely EW. Breathing life into the lifecourse approach: pregnancy history and cardiovascular disease in women. Hypertension 2010; 56 (03) 331-334
- 3 Grandi SM, Filion KB, Yoon S. et al. Cardiovascular disease-related morbidity and mortality in women with a history of pregnancy complications. Circulation 2019; 139 (08) 1069-1079
- 4 Leading causes of death and disability: a visual summary of global and regional trends 2000–2019. Accessed February 22, 2021 at: https://www.who.int/data/stories/leading-causes-of-death-and-disability-2000-2019-a-visual-summary
- 5 American Diabetes Association. 2. Classification and diagnosis of diabetes: Standards of Medical Care in Diabetes-2020. Diabetes Care 2020; 43 (Suppl. 01) S14-S31
- 6 Kramer CK, Campbell S, Retnakaran R. Gestational diabetes and the risk of cardiovascular disease in women: a systematic review and meta-analysis. Diabetologia 2019; 62 (06) 905-914
- 7 American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2014; 37 (Suppl. 01) S81-S90
- 8 Retnakaran R, Qi Y, Connelly PW, Sermer M, Zinman B, Hanley AJ. Glucose intolerance in pregnancy and postpartum risk of metabolic syndrome in young women. J Clin Endocrinol Metab 2010; 95 (02) 670-677
- 9 Xu Y, Shen S, Sun L, Yang H, Jin B, Cao X. Metabolic syndrome risk after gestational diabetes: a systematic review and meta-analysis. PLoS One 2014; 9 (01) e87863
- 10 Durnwald C. Gestational diabetes: Linking epidemiology, excessive gestational weight gain, adverse pregnancy outcomes, and future metabolic syndrome. Semin Perinatol 2015; 39 (04) 254-258
- 11 Noctor E, Crowe C, Carmody LA. et al. ATLANTIC-DIP: prevalence of metabolic syndrome and insulin resistance in women with previous gestational diabetes mellitus by International Association of Diabetes in Pregnancy Study Groups criteria. Acta Diabetol 2015; 52 (01) 153-160
- 12 Nouhjah S, Shahbazian H, Shahbazian N. et al. Early postpartum metabolic syndrome in women with or without gestational diabetes: Results from Life after Gestational Diabetes Ahvaz cohort study. Diabetes Metab Syndr 2018; 12 (03) 317-323
- 13 Shen Y, Li W, Leng J. et al. High risk of metabolic syndrome after delivery in pregnancies complicated by gestational diabetes. Diabetes Res Clin Pract 2019; 150: 219-226
- 14 Grundy SM, Cleeman JI, Daniels SR. et al; American Heart Association, National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112 (17) 2735-2752
- 15 Alberti KG, Zimmet P, Shaw J. Metabolic syndrome–a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 2006; 23 (05) 469-480
- 16 Wilson PW, D'Agostino RB, Parise H, Sullivan L, Meigs JB. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation 2005; 112 (20) 3066-3072
- 17 Gami AS, Witt BJ, Howard DE. et al. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol 2007; 49 (04) 403-414
- 18 Tune JD, Goodwill AG, Sassoon DJ, Mather KJ. Cardiovascular consequences of metabolic syndrome. Transl Res 2017; 183: 57-70
- 19 Papakonstantinou E, Lambadiari V, Dimitriadis G, Zampelas A. Metabolic syndrome and cardiometabolic risk factors. Curr Vasc Pharmacol 2013; 11 (06) 858-879
- 20 Bentley-Lewis R. Late cardiovascular consequences of gestational diabetes mellitus. Semin Reprod Med 2009; 27 (04) 322-329
- 21 Carr DB, Utzschneider KM, Hull RL. et al. Gestational diabetes mellitus increases the risk of cardiovascular disease in women with a family history of type 2 diabetes. Diabetes Care 2006; 29 (09) 2078-2083
- 22 Ram KT, Bobby P, Hailpern SM. et al. Duration of lactation is associated with lower prevalence of the metabolic syndrome in midlife–SWAN, the study of women's health across the nation. Am J Obstet Gynecol 2008; 198 (03) 268.e1-268.e6
- 23 Gunderson EP, Jacobs Jr DR, Chiang V. et al. Duration of lactation and incidence of the metabolic syndrome in women of reproductive age according to gestational diabetes mellitus status: a 20-year prospective study in CARDIA (Coronary Artery Risk Development in Young Adults). Diabetes 2010; 59 (02) 495-504
- 24 Nguyen B, Jin K, Ding D. Breastfeeding and maternal cardiovascular risk factors and outcomes: A systematic review. PLoS One 2017; 12 (11) e0187923
- 25 Yu J, Pudwell J, Dayan N, Smith GN. Postpartum breastfeeding and cardiovascular risk assessment in women following pregnancy complications. J Womens Health (Larchmt) 2020; 29 (05) 627-635
- 26 Stuebe AM, Kleinman K, Gillman MW, Rifas-Shiman SL, Gunderson EP, Rich-Edwards J. Duration of lactation and maternal metabolism at 3 years postpartum. J Womens Health (Larchmt) 2010; 19 (05) 941-950
- 27 Stuebe AM. Does breastfeeding prevent the metabolic syndrome, or does the metabolic syndrome prevent breastfeeding?. Semin Perinatol 2015; 39 (04) 290-295
- 28 Moradi S, Zamani F, Pishgar F, Ordookhani S, Nateghi N, Salehi F. Parity, duration of lactation and prevalence of maternal metabolic syndrome: a cross-sectional study. Eur J Obstet Gynecol Reprod Biol 2016; 201: 70-74
- 29 Choi SR, Kim YM, Cho MS, Kim SH, Shim YS. Association between duration of breast feeding and metabolic syndrome: the Korean national health and nutrition examination surveys. J Womens Health (Larchmt) 2017; 26 (04) 361-367
- 30 Arabin B, Baschat AA. Pregnancy: an underutilized window of opportunity to improve long-term maternal and infant health-an appeal for continuous family care and interdisciplinary communication. Front Pediatr 2017; 5: 69
- 31 Brown CR, Dodds L, Legge A, Bryanton J, Semenic S. Factors influencing the reasons why mothers stop breastfeeding. Can J Public Health 2014; 105 (03) e179-e185
- 32 Carpenter MW, Coustan DR. Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol 1982; 144 (07) 768-773
- 33 National Institutes of Health, National Heart Lung and Blood Institute, North American Asociation for the Study of Obesity. The practical guide: identification, evaluation, and treatment of overweight and obesity in adults. Accessed November 3, 2021 at: https://www.nhlbi.nih.gov/files/docs/guidelines/prctgd_c.pdf
- 34 Swan W, Kilmartin G, Liaw ST. Assessment of readiness to prevent type 2 diabetes in a population of rural women with a history of gestational diabetes. Rural Remote Health 2007; 7 (04) 802
- 35 Johnson ST, Kuk JL, Mackenzie KA, Huang TT, Rosychuk RJ, Ball GD. Metabolic risk varies according to waist circumference measurement site in overweight boys and girls. J Pediatr 2010; 156 (02) 247-52.e1
- 36 Colaizy TT, Saftlas AF, Morriss Jr FH. Maternal intention to breast-feed and breast-feeding outcomes in term and preterm infants: Pregnancy Risk Assessment Monitoring System (PRAMS), 2000-2003. Public Health Nutr 2012; 15 (04) 702-710
- 37 Alberti KG, Eckel RH, Grundy SM. et al; International Diabetes Federation Task Force on Epidemiology and Prevention, Hational Heart, Lung, and Blood Institute, American Heart Association, World Heart Federation, International Atherosclerosis Society, International Association for the Study of Obesity. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009; 120 (16) 1640-1645
- 38 Nicklas JM, Rosner BA, Zera CA, Seely EW. Association between changes in postpartum weight and waist circumference and changes in cardiometabolic risk factors among women with recent gestational diabetes. Prev Chronic Dis 2019; 16: E47
- 39 Liu B, Lamerato LE, Misra DP. A retrospective analysis of the relationship between race/ethnicity, age at delivery and the risk of gestational diabetes mellitus. J Matern Fetal Neonatal Med 2020; 33 (17) 2961-2969
- 40 Moore JX, Chaudhary N, Akinyemiju T. Metabolic syndrome prevalence by race/ethnicity and sex in the United States, National Health and Nutrition Examination Survey, 1988-2012. Prev Chronic Dis 2017; 14: E24
- 41 ACOG. ACOG practice bulletin no. 190: gestational diabetes mellitus. Obstet Gynecol 2018; 131 (02) e49-e64
- 42 Campbell B, Aguilar M, Bhuket T, Torres S, Liu B, Wong RJ. Females, Hispanics and older individuals are at greatest risk of developing metabolic syndrome in the U.S. Diabetes Metab Syndr 2016; 10 (04) 230-233
- 43 Lambrinou CP, Karaglani E, Manios Y. Breastfeeding and postpartum weight loss. Curr Opin Clin Nutr Metab Care 2019; 22 (06) 413-417
- 44 McClure CK, Schwarz EB, Conroy MB, Tepper PG, Janssen I, Sutton-Tyrrell KC. Breastfeeding and subsequent maternal visceral adiposity. Obesity (Silver Spring) 2011; 19 (11) 2205-2213
- 45 Neville CE, McKinley MC, Holmes VA, Spence D, Woodside JV. The relationship between breastfeeding and postpartum weight change–a systematic review and critical evaluation. Int J Obes 2014; 38 (04) 577-590
- 46 Chouinard-Castonguay S, Weisnagel SJ, Tchernof A, Robitaille J. Relationship between lactation duration and insulin and glucose response among women with prior gestational diabetes. Eur J Endocrinol 2013; 168 (04) 515-523
- 47 Herrera E. Metabolic adaptations in pregnancy and their implications for the availability of substrates to the fetus. Eur J Clin Nutr 2000; 54 (Suppl. 01) S47-S51
- 48 Gunderson EP, Lewis CE, Wei GS, Whitmer RA, Quesenberry CP, Sidney S. Lactation and changes in maternal metabolic risk factors. Obstet Gynecol 2007; 109 (03) 729-738
- 49 Knopp RH, Walden CE, Wahl PW. et al. Effect of postpartum lactation on lipoprotein lipids and apoproteins. J Clin Endocrinol Metab 1985; 60 (03) 542-547
- 50 Nguyen PTH, Binns CW, Nguyen CL. et al. Gestational diabetes mellitus reduces breastfeeding duration: a prospective cohort study. Breastfeed Med 2019; 14 (01) 39-45
- 51 Lemay DG, Ballard OA, Hughes MA, Morrow AL, Horseman ND, Nommsen-Rivers LA. RNA sequencing of the human milk fat layer transcriptome reveals distinct gene expression profiles at three stages of lactation. PLoS One 2013; 8 (07) e67531
- 52 Nommsen-Rivers LA, Dolan LM, Huang B. Timing of stage II lactogenesis is predicted by antenatal metabolic health in a cohort of primiparas. Breastfeed Med 2012; 7 (01) 43-49
- 53 Matias SL, Dewey KG, Quesenberry Jr. CP, Gunderson EP. Maternal prepregnancy obesity and insulin treatment during pregnancy are independently associated with delayed lactogenesis in women with recent gestational diabetes mellitus. Am J Clin Nutr 2014; 99 (01) 115-121
- 54 Oza-Frank R, Chertok I, Bartley A. Differences in breast-feeding initiation and continuation by maternal diabetes status. Public Health Nutr 2015; 18 (04) 727-735
- 55 Finkelstein SA, Keely E, Feig DS, Tu X, Yasseen III AS, Walker M. Breastfeeding in women with diabetes: lower rates despite greater rewards. A population-based study. Diabet Med 2013; 30 (09) 1094-1101
- 56 Mäkelä J, Vaarno J, Kaljonen A, Niinikoski H, Lagström H. Maternal overweight impacts infant feeding patterns–the STEPS Study. Eur J Clin Nutr 2014; 68 (01) 43-49
- 57 Chang YS, Glaria AA, Davie P, Beake S, Bick D. Breastfeeding experiences and support for women who are overweight or obese: a mixed-methods systematic review. Matern Child Nutr 2020; 16 (01) e12865
- 58 Krause KM, Lovelady CA, Østbye T. Predictors of breastfeeding in overweight and obese women: data from Active Mothers Postpartum (AMP). Matern Child Health J 2011; 15 (03) 367-375
- 59 Bever Babendure J, Reifsnider E, Mendias E, Moramarco MW, Davila YR. Reduced breastfeeding rates among obese mothers: a review of contributing factors, clinical considerations and future directions. Int Breastfeed J 2015; 10: 21
- 60 Amir LH, Donath S. A systematic review of maternal obesity and breastfeeding intention, initiation and duration. BMC Pregnancy Childbirth 2007; 7: 9
- 61 Stuebe AM, Horton BJ, Chetwynd E, Watkins S, Grewen K, Meltzer-Brody S. Prevalence and risk factors for early, undesired weaning attributed to lactation dysfunction. J Womens Health (Larchmt) 2014; 23 (05) 404-412
- 62 Ross-Cowdery M, Lewis CA, Papic M, Corbelli J, Schwarz EB. Counseling about the maternal health benefits of breastfeeding and mothers' intentions to breastfeed. Matern Child Health J 2017; 21 (02) 234-241
- 63 Ross R, Neeland IJ, Yamashita S. et al. Waist circumference as a vital sign in clinical practice: a Consensus Statement from the IAS and ICCR Working Group on Visceral Obesity. Nat Rev Endocrinol 2020; 16 (03) 177-189
- 64 Montes A, Walden CE, Knopp RH, Cheung M, Chapman MB, Albers JJ. Physiologic and supraphysiologic increases in lipoprotein lipids and apoproteins in late pregnancy and postpartum. Possible markers for the diagnosis of “prelipemia”. Arteriosclerosis 1984; 4 (04) 407-417